论文部分内容阅读
目的探讨高强度聚焦超声(HIFU)治疗晚期胰腺癌的疗效及安全性。方法60例晚期胰腺癌接受HIFU治疗。结果4例完全缓解(CR),22例部分缓解(PR),16例稳定(SD),临床受益反应率(CBR)高达70%;中位生存期5.5个月;所有患者均未见明显不良反应。结论HIFU治疗晚期胰腺癌能取得一定的疗效,治疗安全性高,无痛苦,无并发症,值得临床进一步观察研究。
Objective To investigate the efficacy and safety of high intensity focused ultrasound (HIFU) in the treatment of advanced pancreatic cancer. Methods Sixty patients with advanced pancreatic cancer underwent HIFU treatment. Results Four patients had complete remission (CR), 22 partial remission (PR), 16 stable (SD) patients and a clinically beneficial response rate (CBR) of 70%. The median survival time was 5.5 months. reaction. Conclusion HIFU treatment of advanced pancreatic cancer can achieve a certain effect, the treatment of high security, no pain, no complications, it is worth further clinical observation.